Bill Nygren - Harris Associates L P
Holding/activity history for Glaxosmithkline Plc (AP47)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2012 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2012 Q2 | 24,800 | <0.01 | Reduce 40.51% | <0.01 | $45.56 | $1,130,000 | SEC |
| 2012 Q1 | 41,686 | 0.01 | Add 19.81% | <0.01 | $44.91 | $1,872,000 | SEC |
| 2011 Q4 | 34,794 | 0.01 | Reduce 78.32% | 0.02 | $45.64 | $1,588,000 | SEC |
| 2011 Q3 | 160,485 | 0.02 | Reduce 90.25% | 0.21 | $41.29 | $6,626,000 | SEC |
| 2011 Q2 | 1,645,251 | 0.23 | Reduce 0.60% | <0.01 | $42.90 | $70,582,000 | SEC |
| 2011 Q1 | 1,655,257 | 0.21 | Reduce 0.39% | <0.01 | $38.41 | $63,579,000 | SEC |
| 2010 Q4 | 1,661,757 | 0.21 | Reduce 1.90% | <0.01 | $39.22 | $65,174,000 | SEC |
| 2010 Q3 | 1,693,857 | 0.33 | Reduce 0.67% | <0.01 | $39.52 | $66,941,000 | SEC |
| 2010 Q2 | 1,705,280 | 0.26 | Reduce 0.40% | <0.01 | $34.01 | $57,997,000 | SEC |
| 2010 Q1 | 1,712,083 | 0.24 | Reduce 2.53% | <0.01 | $38.52 | $65,949,000 | SEC |
| 2009 Q4 | 1,756,499 | 0.30 | Reduce 9.33% | 0.04 | $42.25 | $74,212,000 | SEC |
| 2009 Q3 | 1,937,324 | 0.38 | Reduce 2.73% | 0.01 | $39.51 | $76,544,000 | SEC |
| 2009 Q2 | 1,991,624 | 0.44 | Reduce 1.56% | <0.01 | $35.34 | $70,384,000 | SEC |
| 2009 Q1 | 2,023,145 | 0.45 | Reduce 3.57% | 0.01 | $31.07 | $62,859,000 | SEC |
| 2008 Q4 | 2,098,045 | 0.41 | Buy | 0.41 | $37.27 | $78,194,000 | SEC |
| 2008 Q1 | 0 | 0.00 | Sell 100.00% | 0.38 | SEC | ||
| 2007 Q4 | 1,543,983 | 0.38 | Add 1.65% | <0.01 | $50.39 | $77,801,000 | SEC |
| 2007 Q3 | 1,518,994 | 0.23 | Add 4,772.94% | 0.23 | $53.20 | $80,810,000 | SEC |
| 2007 Q2 | 31,172 | 0.01 | Reduce 39.53% | <0.01 | $52.35 | $1,632,000 | SEC |
| 2007 Q1 | 51,552 | 0.01 | Add 0.74% | <0.01 | $55.26 | $2,849,000 | SEC |
| 2006 Q4 | 51,172 | 0.01 | $52.76 | $2,700,000 | SEC | ||
| 2006 Q3 | 51,172 | 0.01 | Reduce 0.28% | $53.23 | $2,724,000 | SEC | |
| 2006 Q2 | 51,315 | 0.01 | Reduce 1.11% | <0.01 | $55.79 | $2,863,000 | SEC |
| 2006 Q1 | 51,893 | 0.01 | Add 0.38% | $52.30 | $2,714,000 | SEC | |
| 2005 Q4 | 51,697 | 0.01 | Add 0.11% | $50.49 | $2,610,000 | SEC | |
| 2005 Q3 | 51,640 | 0.01 | $51.28 | $2,648,000 | SEC | ||
| 2005 Q2 | 51,640 | 0.01 | Add 0.28% | $48.51 | $2,505,000 | SEC | |
| 2005 Q1 | 51,497 | 0.01 | Add 0.64% | <0.01 | $45.93 | $2,365,000 | SEC |
| 2004 Q4 | 51,172 | 0.01 | Reduce 4.34% | <0.01 | $47.39 | $2,425,000 | SEC |
| 2004 Q3 | 53,492 | 0.01 | Reduce 1.47% | <0.01 | $43.73 | $2,339,000 | SEC |
| 2004 Q2 | 54,292 | 0.01 | Reduce 5.43% | <0.01 | $41.46 | $2,251,000 | SEC |
| 2004 Q1 | 57,411 | 0.01 | Reduce 0.25% | $39.96 | $2,294,000 | SEC | |
| 2003 Q4 | 57,554 | 0.01 | Add 5.73% | <0.01 | $46.62 | $2,683,000 | SEC |
| 2003 Q3 | 54,435 | 0.01 | $42.40 | $2,308,000 | SEC | ||
| 2003 Q2 | 54,435 | 0.01 | Reduce 14.76% | <0.01 | $40.54 | $2,207,000 | SEC |
| 2003 Q1 | 63,862 | 0.01 | Add 0.36% | $35.19 | $2,247,000 | SEC | |
| 2002 Q4 | 63,635 | 0.01 | $37.46 | $2,384,000 | SEC | ||
| 2002 Q3 | 63,635 | 0.01 | Buy | 0.01 | $38.42 | $2,445,000 | SEC |